Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Frostman who wrote (8811)	6/1/1998 11:08:00 AM
From: RT	Read Replies (3) \| Respond to of 23519

Isn't today the day we were led to believe the plant would be approved? It's unbelievable that it's been five months waiting for FDA plant approval. Hell, they built the plant in less than a year. If the script number don't reverse shortly, they may not need both plants. They can set up shop in my spare bathroom and save big time. <<gg>> The plant in Ireland needs to be put on temporary / permanent hold until we see some encouraging script numbers. Even before the competition Muse's refill numbers were disappointing. 500K users and the refill's numbers barely exceeded 5,200. We heard all the excuses that the numbers where incorrect do to production constraints. This apparently is not the case. Users are dissatisfied and not reordering. It appears they are not being adequately instructed on the proper administration of the drug and hence the high failure rate. The few muse users or x users we've heard from never knew about the Actis band and the procedure for its use. Is Dr. Edderd the only one who informs his patients on the proper usage of this product? It appears doctors are either to busy or embarrassed to see that the patient is properly instructed. Let's hope to see some encouraging script numbers today. RT